Seong-Wook Lee
Chief Executive Officer Rznomics Inc.
Dr. Seong-Wook Lee is a full Professor at Dankook University. He received a BSc and MSc from Seoul National University and a PhD from Cornell University. He founded Rznomics Inc., an RNA-based biopharmaceutical company, in 2017 and has served as President and CEO. His areas of expertise include the development of RNAs as gene therapeutics and diagnostics, especially developing RNAs for the treatment and prevention of diverse intractable diseases, including genetic, infectious, degenerative, and malignant diseases. He serves as an editorial board member of renowned international journals, especially in nucleic acid gene therapy, including Nucleic Acid Therapeutics and Molecular Therapy-Nucleic Acid. He served as President of the Korean Society of Gene and Cell Therapy.
Seminars
- Exploring the latest RNA editing approaches to target APOE, such as Rznomics’ trans-splicing-induced replacement of APOE4
- Discussing the potential of RNAi platforms to transverse the BBB and silence disease-causing genes in the brain
- Evaluating opportunities for ASOs, such as Sovargen’s SVG105, to achieve greater efficacy than conventional gene and small molecule therapies in epilepsies
- Evaluating novel exosome-based and lipid carrier platforms for CNS-targeted RNA therapeutics
